CClinicalTrials.gg
CompletedNCT00665691Updated Apr 26, 2017

Pilot Test for a Newly Developed Nutrition Screening Method: Pediatric Subjective Global Assessment

An observational study in Compare Two Nutrition Screening Tools, sponsored by St. Jude Children's Research Hospital. Completed at 1 site in United States. Open to participants aged 2 Years to 16 Years. Per ClinicalTrials.gov, last updated 2017-04-26.

Sponsored by St. Jude Children's Research Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
132
Ages
2 Years to 16 Years
Sex
All
01

Study summary

Researchers are studying ways to predict if cancer patients are at risk for poor nutrition during their chemotherapy treatment. They hope to identify children with nutrition problems early in treatment. This may help prevent weight loss and other nutrition problems later in treatment.

Read the detailed description

The PEDSGA is a newly developed nutrition tool that includes a training manual that be used to teach health care professionals to identify at-risk patients by doing a nutrition physical exam. The PEDSGA also includes questions that the patient/caregiver answers regarding appetite, recent treatment, and activity level. This method of screening is new and may be able to identify at-risk patients better than the standard method. This study will use both methods and evaluate the two, in hope of determining which method works best to identify at-risk patients.

02

Conditions studied

  • Compare Two Nutrition Screening Tools

Keywords

  • All Malignancies
03

In context

Lead sponsor

St. Jude Children's Research Hospital is the lead sponsor of 434 studies on the registry; 99 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 35 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Participant is between 2 and 16 years of age and receiving treatment for a hematologic or solid malignancy at St. Jude Children's Research Hospital.

Eligibility criteria

Inclusion Criteria:

  • St. Jude Children's Research Hospital patient between 2 and 16 years of age who is actively receiving treatment for a hematologic or solid tumor malignancy
  • Patient is not admitted to the transplant service
  • Patient is able to read English or Spanish
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
132 participants (actual)

Groups and cohorts

  • 1

    Other: Nutritional Screening Tools

Interventions

  • OtherNutritional Screening Tools

    To compare the nutrition risk identification abilities of two nutrition screening tools: PEDSGA tool and the standard assessment tool.

06

What researchers measure

Primary outcomes

  1. To compare the ability of two nutrition screening tools to identify nutritionally at risk patients

    Time frame: Within 90 days of study completion

07

Study locations

1 site
  • St. Jude Children's Research Hospital
    Memphis, Tennessee 38105, United States
08

References and documents

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 26, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00665691
Lead sponsor
St. Jude Children's Research Hospital
Responsible party
Sponsor
First posted
Apr 24, 2008
Start date
Sep 2003
Primary completion
Jul 2010
Completion
Jul 2010
Last update
Apr 26, 2017

Study contacts

Karen Smith, RD, MS, LDN
principal investigator · St. Jude Children's Research Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion